Prescribing Experiences, Potentials, and Challenges of Digital Health Applications in the Field of Hormones and Metabolism: Cross-Sectional Survey Study of Health Care Providers in Germany.

ABSTRACT:

Background

In 2020, the global prevalence of overweight and obesity was approximately 42%. One of the most common associated conditions is type 2 diabetes mellitus, which had a global prevalence of around 10.5% in 2021. Digital health applications (DiHA), which can be prescribed as certified medical devices in Germany, have been shown to effectively support disease management in patients with overweight and diabetes mellitus. However, little is known about DiHA-prescribing behavior of health care providers (HCPs) specializing in hormones and metabolism or about potential barriers to prescribing these applications.

Objective

This study aimed to assess HCPs' experience with and willingness to prescribe DiHA in the field of hormones and metabolism. In addition, it sought to exa

SUBMITTER: Mader M 

PROVIDER: S-EPMC12805319 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature